HealthcareServices

Vaccine Contract Manufacturing Market Future Outlook 2026: Key Drivers and Growth Potential

March 3, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the vaccine contract manufacturing market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Vaccine Contract Manufacturing Market in 2030?

The vaccine contract manufacturing market size has experienced significant expansion in recent years. This market is projected to expand from $3.88 billion in 2025 to $4.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.0%. Historically, this growth was driven by factors such as the broadening of global immunization initiatives, the escalating intricacy of vaccine production methods, a greater dependence on specialized contract manufacturers, the rise of public-private collaborations in vaccines, and the development of extensive vaccine production facilities.

The vaccine contract manufacturing market is projected to experience substantial expansion in the coming years. This market is set to reach $6.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This anticipated growth over the forecast period stems from factors such as an escalating need for swift vaccine scale-up, augmented investments in mRNA and advanced vaccine types, the broadening of commercial-scale production, an intensifying emphasis on achieving regional vaccine autonomy, and the integration of cutting-edge bioprocess technologies. Key trends during this period are expected to encompass a surge in the outsourcing of vaccine manufacturing, an elevated requirement for adaptable production capacities, the broadening of fill-finish service offerings, a heightened commitment to manufacturing compliant with regulations, and a greater uptake of single-use bioprocessing systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp

What Drivers Are Influencing Production Trends In The Vaccine Contract Manufacturing Market?

The global rise in infectious diseases is anticipated to stimulate the expansion of the vaccine contract manufacturing market. Infectious diseases are defined as conditions caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. When outbreaks of infectious diseases occur, like influenza, measles, or emerging viruses, there is an immediate requirement for vaccines to prevent wider dissemination. Contract manufacturers are capable of rapidly scaling up production to address these outbreaks. For instance, in October 2024, the World Health Organization, an international public health organization based in Switzerland, reported that approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, solidifying tuberculosis’s position as the leading infectious disease killer. Therefore, the growing prevalence of infectious diseases worldwide is fueling the growth of the vaccine contract manufacturing market.

Which Segments Are Gaining Traction In The Vaccine Contract Manufacturing Market?

The vaccine contract manufacturing market covered in this report is segmented –

1) By Service Type: Fill-Finish, Bulk Product

2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines

3) By Process: Downstream, Upstream

4) By Scale Of Operation: Preclinical, Clinical, Commercial

5) By End-Use: Human Use, Veterinary

Subsegments:

1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling

2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation

Which Trends Are Shaping Activity Within The Vaccine Contract Manufacturing Market?

Major companies engaged in the vaccine contract manufacturing market are prioritizing the establishment of new production sites to sustain their competitive edge. The opening of such facilities pertains to setting up dedicated sites for the contractual manufacturing and production of vaccines. For example, in September 2023, WuXi Vaccines, a China-based contract development and manufacturing organization (CDMO) focused on vaccine discovery and production, launched its first independent vaccine CDMO site in Suzhou, China. This expansion signifies a major milestone for the company, introducing enhanced capabilities for both drug substance and drug product manufacturing. WuXi Vaccines now provides a full spectrum of services, including process development, drug product development, and the production of clinical-scale drug substances (DS) and small-to-medium sterile drug products (DP). The new standalone facility significantly increases WuXi Vaccines’ capacity to contribute to vaccine development and manufacturing, thereby playing a vital role in advancing global healthcare solutions.

Who Are The Major Companies Operating In The Vaccine Contract Manufacturing Market?

Major companies operating in the vaccine contract manufacturing market are Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Bio Farma, Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/vaccine-contract-manufacturing-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Vaccine Contract Manufacturing Market?

North America was the largest region in the vaccine contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Vaccine Contract Manufacturing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12216&type=smp

Browse Through More Reports Similar to the Global Vaccine Contract Manufacturing Market 2026, By The Business Research Company

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Antibody Contract Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report

Biopharmaceuticals Contract Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795